Cargando…
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529047/ https://www.ncbi.nlm.nih.gov/pubmed/36204692 http://dx.doi.org/10.1097/HS9.0000000000000778 |
_version_ | 1784801420608798720 |
---|---|
author | Gerds, Aaron T. Bose, Prithviraj Hobbs, Gabriela S. Kuykendall, Andrew T. Neilson, Lynn M. Song, Jinlin Klencke, Barbara Harrison, Claire N. |
author_facet | Gerds, Aaron T. Bose, Prithviraj Hobbs, Gabriela S. Kuykendall, Andrew T. Neilson, Lynn M. Song, Jinlin Klencke, Barbara Harrison, Claire N. |
author_sort | Gerds, Aaron T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9529047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-95290472022-10-05 Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications Gerds, Aaron T. Bose, Prithviraj Hobbs, Gabriela S. Kuykendall, Andrew T. Neilson, Lynn M. Song, Jinlin Klencke, Barbara Harrison, Claire N. Hemasphere Perspective Lippincott Williams & Wilkins 2022-09-30 /pmc/articles/PMC9529047/ /pubmed/36204692 http://dx.doi.org/10.1097/HS9.0000000000000778 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Perspective Gerds, Aaron T. Bose, Prithviraj Hobbs, Gabriela S. Kuykendall, Andrew T. Neilson, Lynn M. Song, Jinlin Klencke, Barbara Harrison, Claire N. Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title | Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title_full | Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title_fullStr | Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title_full_unstemmed | Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title_short | Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications |
title_sort | treating anemic patients with myelofibrosis in the new janus kinase inhibitor era: current evidence and real-world implications |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529047/ https://www.ncbi.nlm.nih.gov/pubmed/36204692 http://dx.doi.org/10.1097/HS9.0000000000000778 |
work_keys_str_mv | AT gerdsaaront treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT boseprithviraj treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT hobbsgabrielas treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT kuykendallandrewt treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT neilsonlynnm treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT songjinlin treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT klenckebarbara treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications AT harrisonclairen treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications |